OGEN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OGEN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Oragenics's EPS without NRI for the three months ended in Mar. 2024 was $-0.70.
During the past 3 years, the average EPS without NRI Growth Rate was 31.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 31.70% per year. During the past 10 years, the average EPS without NRI Growth Rate was 31.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Oragenics was 50.80% per year. The lowest was 4.10% per year. And the median was 29.10% per year.
For the Biotechnology subindustry, Oragenics's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Oragenics's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Oragenics's 3-Year EPS without NRI Growth Rate falls into.
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
Oragenics (AMEX:OGEN) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Thank you for viewing the detailed overview of Oragenics's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Fred Telling | director | 501 ELLIOTT AVE. W., SUITE 400, SEATTLE WA 98119 |
John P Gandolfo | director | 62 TERRACE ROAD, WAYNE NJ 07470 |
Cassidy Bruce A. Sr. | director | C/O LOOP MEDIA, 700 N CENTRAL AVENUE, SUITE 430, GLENDALE CA 91203 |
Janet Huffman | officer: CFO, Secretary and Treasurer | 5317 FRUITVILLE RD SUITE 6, SARASOTA FL 34232 |
Robert C Koski | director, 10 percent owner | 1500 W UNIVERSITY PARKWAY, SARASOTA FL 34243 |
Michael O'keefe Sullivan | officer: CFO, Secretary and Treasurer | 3000 BAYPORT DRIVE, SUITE 685, TAMPA FL 33607 |
Joseph Hernandez | 10 percent owner | C/O MICROLIN BIO, INC., NEW YORK NY 10022 |
Kimberly M Murphy | director | 101 EAST KENNEDY BLVD., SUITE 2800, TAMPA FL 33602 |
Koski Family Lp | 10 percent owner | 1500 W UNIVERSITY PARKWAY, SARASOTA FL 34243 |
Randal J Kirk | 10 percent owner | 1881 GROVE AVENUE, RADFORD VA 24141 |
Alan Joslyn | director, officer: CEO and President | 39 OLD RIDGEBURY ROAD, DANBURY CT 06810 |
Charles L Pope | director | 4902 EISENHOWER BOULEVARD, TAMPA FL 33634 |
Christine L Koski | director, 10 percent owner | 1500 WEST UNIVERSITY PARKWAY, SARASOTA FL 34243 |
Beverly Koski | 10 percent owner | |
Thomas L Koski | 10 percent owner |
From GuruFocus
By Marketwired Marketwired • 06-20-2018
By GuruFocus Research GuruFocus Editor • 01-14-2022
By PRNewswire PRNewswire • 01-04-2022
By PRNewswire PRNewswire • 07-10-2020
By PRNewswire PRNewswire • 10-04-2018
By PRNewswire PRNewswire • 08-20-2020
By PRNewswire PRNewswire • 07-22-2020
By PRNewswire PRNewswire • 05-19-2020
By PRNewswire PRNewswire • 10-06-2020
By PRNewswire PRNewswire • 12-20-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.